Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
2.49
1.99
NAV
₹505.95
₹38.69
Fund Started
10 May 2004
25 Jun 2018
Fund Size
₹7898.24 Cr
₹6293.14 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
2.11%
4.37%
3 Year
21.53%
25.91%
5 Year
13.06%
15.56%
Equity
99.45%
97.62%
Cash
0.54%
2.35%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.92% |
Lupin Ltd. | 8.45% |
Divi's Laboratories Ltd. | 6.41% |
Dr. Reddy's Laboratories Ltd. | 5.96% |
Cipla Ltd. | 5.42% |
Apollo Hospitals Enterprise Ltd. | 5.15% |
Medplus Health Services Ltd. | 3.86% |
Ajanta Pharma Ltd. | 3.36% |
Max Healthcare Institute Ltd. | 3.24% |
Vijaya Diagnostic Centre Ltd. | 3.15% |
Sun Pharmaceutical Industries Ltd. | 12.11% |
Cipla Ltd. | 9.23% |
Mankind Pharma Ltd. | 7.01% |
Biocon Ltd. | 6.08% |
Dr. Reddy's Laboratories Ltd. | 5.97% |
Divi's Laboratories Ltd. | 5.91% |
Lupin Ltd. | 4.09% |
Alkem Laboratories Ltd. | 3.52% |
Syngene International Ltd. | 3.52% |
Aurobindo Pharma Ltd. | 3.30% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 May 2004
25 Jun 2018
